Human Oncology & Pathogenesis Program

The Michael Roehrl Lab

Research

Michael H. A.  Roehrl, MD, PhD
Michael H. A. Roehrl, MD, PhD
Director, Precision Pathology Biobanking Center; Associate Pathologist

An overarching theme of my laboratory’s work is the experimental investigation of the network behavior of biological systems relevant to human disease using a variety of biochemical, biophysical, molecular biological, and systems modeling approaches. A primary focus is the biology of gastrointestinal solid tumors such as colorectal and pancreatic cancers.

View Lab Overview

Research Projects

The Michael Roehrl Lab

Publications

View All Publications

People

Michael H. A.  Roehrl, MD, PhD

Michael H. A. Roehrl, MD, PhD

Director, Precision Pathology Biobanking Center; Associate Pathologist

View physician profile
Physician profile

Members

Kei Namba

Research Fellow

Makiko Ogawa

Research Fellow

Atushi Tanaka

Research Fellow

Lab Affiliations

Open Positions

Postdoctoral Fellows

Apply now

Research Pathologist/Scientist for the Precision Pathology Biobanking Center (PPBC) at MSKCC

Apply now

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michael H. A. Roehrl discloses the following relationships and financial interests:

  • Gerson Lehrman Group
    Provision of Services
  • Proscia
    Provision of Services
  • Trans-Hit Biomarkers Inc.
    Provision of Services
  • Universal Diagnostics (UDX)
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures